Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,729 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,369
Recruiting: 3,967
Ph III recruiting: 537
Growth YoY: +9.4%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,405)

clinicaltrialsPublishedShowing 551–600 of 1,620 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07598318	Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations	not yet recruiting	Phase 2 / Phase 3	164	Sir Run Run Shaw HospitalOTHER	0	May 20, 2026	clinicaltrials
NCT07599163	Oral Paclitaxel as Neoadjuvant Therapy in Elderly NSCLC: A Phase II Trial	not yet recruiting	N/A	75	Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER	0	May 20, 2026	clinicaltrials